<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2</volume><submitter>Kasper BS</submitter><pubmed_abstract>50 years ago back in 1971, David C. Taylor and colleagues from England reported on a small series of surgical epilepsy cases proposing a new type of tissue lesion as a cause of difficult-to-treat focal epilepsy: a localized malformation of cerebral cortex. The lesion is now known as focal cortical dysplasia (FCD) Type II or Taylor's cortical dysplasia. FCD II is not rare, and today is a frequent finding in neurosurgical epilepsy specimens. Medical progress has been achieved in that the majority of FCD II is diagnosed non-invasively by magnetic resonance imaging today. Detailed studies on FCD revealed that the lesion belongs to a spectrum of mTOR-o-pathies, thereby confirming the authors´ initial hypothesis of a relationship to tuberous sclerosis. Here, selected original materials from Tayl</pubmed_abstract><journal>Free neuropathology</journal><pagination>11</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10240934</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Taylor's focal cortical dysplasia revisited: History, original specimens and impact.</pubmed_title><pmcid>PMC10240934</pmcid><pubmed_authors>Kasper BS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Taylor's focal cortical dysplasia revisited: History, original specimens and impact.</name><description>50 years ago back in 1971, David C. Taylor and colleagues from England reported on a small series of surgical epilepsy cases proposing a new type of tissue lesion as a cause of difficult-to-treat focal epilepsy: a localized malformation of cerebral cortex. The lesion is now known as focal cortical dysplasia (FCD) Type II or Taylor's cortical dysplasia. FCD II is not rare, and today is a frequent finding in neurosurgical epilepsy specimens. Medical progress has been achieved in that the majority of FCD II is diagnosed non-invasively by magnetic resonance imaging today. Detailed studies on FCD revealed that the lesion belongs to a spectrum of mTOR-o-pathies, thereby confirming the authors´ initial hypothesis of a relationship to tuberous sclerosis. Here, selected original materials from Tayl</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jan</publication><modification>2026-06-06T22:11:57.208Z</modification><creation>2025-04-19T17:50:45.139Z</creation></dates><accession>S-EPMC10240934</accession><cross_references><pubmed>37284620</pubmed><doi>10.17879/freeneuropathology-2021-3324</doi></cross_references></HashMap>